What question did this study set out to answer?

The aim is to evaluate medication satisfaction and quality-of-life improvements among Chinese patients with NMOSD receiving inebilizumab.

June 13, 2026Neurology

A Real-world Survey on Medication Satisfaction of Inebilizumab in Chinese Patients with NMOSD (P7-1.011)

View Full Paper

Ask AI

Bookmark

Authors

Real-world survey assesses medication satisfaction in Chinese NMOSD patients treated with inebilizumab, suggesting implications for care.

The aim is to evaluate medication satisfaction and quality-of-life improvements among Chinese patients with NMOSD receiving inebilizumab.
Conducted a real-world survey of Chinese patients with NMOSD
Assessed medication satisfaction and quality of life improvements
Collected data to inform clinical decision-making and patient-centered care
Patients reported improved medication satisfaction after treatment with inebilizumab
Significant quality-of-life enhancements were observed in the surveyed population
Findings support the use of inebilizumab in clinical practice for NMOSD patients

Xu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark